Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial

被引：3

作者：

Correll, Christoph U. ^{[1
,2
,3
]}

Miller, Andrew C. ^{[4
]}

Sawchak, Sharon ^{[4
]}

Kaul, Inder ^{[4
]}

Paul, Steven M. ^{[4
]}

Brannan, Stephen K. ^{[4
]}

机构：

[1] Zucker Hillside Hosp, Glen Oaks, NY USA

[2] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Hempstead, NY USA

[3] Charite Univ Med Berlin, Berlin, Germany

[4] Karuna Therapeut, Boston, MA USA

来源：

CNS SPECTRUMS | 2023年 / 28卷 / 02期

关键词：

D O I：

10.1017/S1092852923001360

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：220 / 220

页数：1

共 50 条

[21] The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
McMurray, John J. V.
Freeman, Mason W.
Massaro, Joe
Solomon, Scott
Lock, Paul
Riddle, Matthew C.
Halvorsen, Yuan-Di C.
DIABETES, 2020, 69
[22] Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
Karbalaee, Monire
Jameie, Melika
Amanollahi, Mobina
TaghaviZanjani, Fateme
Parsaei, Mohammadamin
Basti, Fatemeh A.
Mokhtari, Saba
Moradi, Kamyar
Akhondzadeh, Shahin
SCHIZOPHRENIA RESEARCH, 2023, 254 : 92 - 98
[23] Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
Miyaoka, Tsuyoshi
Furuya, Motohide
Horiguchi, Jun
Wake, Rei
Hashioka, Sadayuki
Thoyama, Masaya
Murotani, Kenta
Mori, Norio
Minabe, Yoshio
Iyo, Masaomi
Ueno, Shuichi
Ezoe, Sachiko
Hoshino, Syuzo
Seno, Haruo
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
[24] Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
Allen, Michael H.
Feifel, David
Lesem, Michael D.
Zimbroff, Daniel L.
Ross, Ruth
Munzar, Patrik
Spyker, Daniel A.
Cassella, James V.
JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (10) : 1313 - 1321
[25] Efficacy of trospium chloride in patients with detrusor instability:: a placebo-controlled, randomized, double-blind, multicentre clinical trial
Cardozo, L
Chapple, CR
Toozs-Hobson, P
Grosse-Freese, M
Bulitta, M
Lehmacher, W
Strösser, W
Ballering-Brühl, B
Schäfer, M
BJU INTERNATIONAL, 2000, 85 (06) : 659 - 664
[26] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
Campillo, Jeremy T.
Bikita, Paul
Hemilembolo, Marlhand
Louya, Frederic
Missamou, Francois
Pion, Sebastien D. S.
Boussinesq, Michel
Chesnais, CedricB
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27
[27] Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Garbutt, James C.
Kampov-Polevoy, Alexei B.
Gallop, Robert
Kalka-Juhl, Linda
Flannery, Barbara A.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (11) : 1849 - 1857
[28] Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial
Maria, Morais-Socorro
Alvaro, Cavalcanti Maciel
Rand, Martins
Paulo, Neto Francisco
Adriana, Rezende
George, Azevedo
Maria, Almeida
GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (06) : 483 - 487
[29] Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Patients: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
Zhang, Xiao
Xu, Huji
Zhang, Zhiyi
Li, Yang
Pauer, Lynne
Liao, Shanmei
Xu, Gaiping
Zhang, Fengchun
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[30] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Hassanien, M.
Moshrif, A.
Hetta, H.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35

← 1 2 3 4 5 →